New Alzheimer's drug 'Aducanumab' from the American pharmaceutical company Biogen, not only stops the advance of Alzheimer's - it reverses the damage done. The pharmaceutical company in a press release said that the drug performed well in initial trails and they are planning for a second phase trail. "Treatment with aducanumab produced a dose-and-time-dependent reduction of amyloid plaque in the brain. Amyloid plaque is believed to play a key role ...
http://ift.tt/1GIPEuv
http://ift.tt/1BWgEAm
No comments:
Post a Comment